Corrections:
Correction: MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene
Metrics: PDF 2506 views | ?
1 Cancer Epigenetics Program, Anhui Cancer Hospital, West District of Anhui Provincial Hospital, Hefei 230031, Anhui, China
2 Department of Clinical Geriatrics, Anhui Provincial Hospital, Hefei 230031, Anhui, China
3 Indiana University School of Medicine, Indianapolis, IN 46202, USA
4 Department of Radiation Oncology, Anhui Cancer Hospital, West District of Anhui Provincial Hospital, Hefei 230031, Anhui, China
5 Xinxiang Medical University, Xinxiang 453000, Henan, China
6 Department of Orthopedic Surgery, Anhui Cancer Hospital, West District of Anhui Provincial Hospital, Hefei 230031, Anhui, China
* These authors have contributed equally to this work
Published: September 01, 2017
This article has been corrected: Dr. Shanbao Cai was moved to the first position in the author list. The authors sincerely apologize for this oversight.
Original article: Oncotarget. 2016;7:28420-34. DOI:https://doi.org/10.18632/oncotarget.8546.
![Creative Commons License](/images/80x15.png)
PII: 20599